Osteoarthritis
Conditions
Interventions
experimental group:Loxoprofen Sodium Gel Cataplasm
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
40 Years to 78 Years
Inclusion criteria
Inclusion criteria: 1. Subjects voluntarily agree to participate in this study and sign a written informed consent form; 2. Aged from 40 to 78 years, regardless of gender; 3. After clinical diagnosis, it is diagnosed as a patient with osteoarthritis; 4. The study/control medication used by the patient is in the medication list specified in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with bleeding disorders; 2. Patients with bronchial asthma; 3. Patients with severe heart, liver, and kidney dysfunction; 4. Pregnant and lactating women or women of childbearing age who are about to conceive; 5. Those who are known to be allergic to non-steroidal anti-inflammatory drugs; 6. Patients who have participated in clinical studies of other drugs within one month; 7. Other concomitant diseases or complications that may affect the observation of curative effects (partial skin breakage, infection, skin rash).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate of treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale;WOMAC score;Lysholm score; | — |
Countries
China
Contacts
Public ContactXu Weihua
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed